Alvotech ALVO

NAS: ALVO | ISIN: LU2458332611   30/06/2025
9,120 USD (-0,22%)
(-0,22%)   30/06/2025

2 juli 2025 · Granting of Stock Options and Vesting of Restricted Share Units · Persbericht

1 juli 2025 · Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) · Persbericht

26 juni 2025 · Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility · Persbericht

25 juni 2025 · Main Results of 2025 Annual and Extraordinary General Meeting · Persbericht

25 juni 2025 · Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab) · Persbericht

23 juni 2025 · European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept) · Persbericht

11 juni 2025 · Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors · Persbericht

6 juni 2025 · Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami · Persbericht

5 juni 2025 · Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) · Persbericht

5 juni 2025 · Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million · Persbericht

4 juni 2025 · Alvotech intends to carry out a private placement of approximately 7.5 million SDRs and ordinary shares · Persbericht

4 juni 2025 · Alvotech Completes Acquisition of Xbrane R&D Organization and biosimilar candidate to Cimzia® · Persbericht

2 juni 2025 · Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY · Persbericht

28 mei 2025 · Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe · Persbericht

26 mei 2025 · Alvotech Annual General Meeting to be held June 25, 2025 · Persbericht

23 mei 2025 · Transactions of Managers and Closely Associated Persons · Persbericht

19 mei 2025 · Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm · Persbericht

19 mei 2025 · Trading in Alvotech’s Shares on Nasdaq Stockholm Commences Today · Persbericht

16 mei 2025 · Alvotech Announces the Outcome of the Offering in Connection with the Company’s Listing on Nasdaq Stockholm · Persbericht

16 mei 2025 · Transactions of Managers and Closely Associated Persons · Persbericht

Mijn selecties